Wireless Pulse Oximeter Shares Data with Mobile Devices
By HospiMedica International staff writers Posted on 16 Aug 2015 |
Image: The MightySat Rx fingertip wireless pulse oximeter (Photo courtesy of Masimo).
An innovative wireless fingertip pulse oximeter enables clinicians to track and trend measurements through smart mobile devices.
The Masimo MightySat Rx Pulse Oximeter provides oxygen saturation (SpO2), pulse rate, Perfusion Index (PI), and Pleth Variability Index (PVI) using Masimo SET measure-through motion and low perfusion pulse oximetry technology. The Bluetooth-enabled device allow clinicians to track and trend up to 12 hours of patient measurements on smart mobile devices, and to share that data via standard comma-separated-value (CSV) files, as well as transfer the data to the Apple (Cupertino, CA, USA) Health app.
The MightySat Rx Pulse Oximeter is intended for adult and pediatric patients, even during motion and low perfusion. Standard features include Signal IQ to assess measurement confidence; a rugged, lightweight design for operation in challenging environments; a long battery life of up to 15 hours with two standard AAA alkaline batteries; and a comfortable design with a silicon finger pad that molds to patients' fingers. The Masimo MightySat Rx Pulse Oximeter is a product of Masimo (Irvine, CA, USA), and has received the European Community CE marking of approval.
“Many clinicians around the world rely on pulse oximetry as the fifth vital sign. To deliver Masimo SET performance in this low-power form factor took some engineering, given the precision of our technology and SET's computationally intensive algorithm," said Joe Kiani, Founder & CEO of Masimo. “We actually dropped the power consumption by nearly two orders of magnitude. But the development effort was worth it, as we expect this technology will empower clinicians and they will no longer have to compromise performance for mobility.”
Conventional pulse oximetry assumes arterial blood is the only blood pulsating at the measurement site. However, during patient motion, venous blood also moves, causing conventional pulse oximetry to under-read since it cannot distinguish between arterial and venous blood. Masimo SET signal processing identifies the venous blood signal, isolates it, and uses adaptive filters to cancel it, extracting the arterial signal in order to report the true arterial oxygen saturation and pulse rate.
Related Links:
Masimo
Apple
The Masimo MightySat Rx Pulse Oximeter provides oxygen saturation (SpO2), pulse rate, Perfusion Index (PI), and Pleth Variability Index (PVI) using Masimo SET measure-through motion and low perfusion pulse oximetry technology. The Bluetooth-enabled device allow clinicians to track and trend up to 12 hours of patient measurements on smart mobile devices, and to share that data via standard comma-separated-value (CSV) files, as well as transfer the data to the Apple (Cupertino, CA, USA) Health app.
The MightySat Rx Pulse Oximeter is intended for adult and pediatric patients, even during motion and low perfusion. Standard features include Signal IQ to assess measurement confidence; a rugged, lightweight design for operation in challenging environments; a long battery life of up to 15 hours with two standard AAA alkaline batteries; and a comfortable design with a silicon finger pad that molds to patients' fingers. The Masimo MightySat Rx Pulse Oximeter is a product of Masimo (Irvine, CA, USA), and has received the European Community CE marking of approval.
“Many clinicians around the world rely on pulse oximetry as the fifth vital sign. To deliver Masimo SET performance in this low-power form factor took some engineering, given the precision of our technology and SET's computationally intensive algorithm," said Joe Kiani, Founder & CEO of Masimo. “We actually dropped the power consumption by nearly two orders of magnitude. But the development effort was worth it, as we expect this technology will empower clinicians and they will no longer have to compromise performance for mobility.”
Conventional pulse oximetry assumes arterial blood is the only blood pulsating at the measurement site. However, during patient motion, venous blood also moves, causing conventional pulse oximetry to under-read since it cannot distinguish between arterial and venous blood. Masimo SET signal processing identifies the venous blood signal, isolates it, and uses adaptive filters to cancel it, extracting the arterial signal in order to report the true arterial oxygen saturation and pulse rate.
Related Links:
Masimo
Apple
Latest Health IT News
- Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
- Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
- AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
- AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
- First Fully Autonomous Generative AI Personalized Medical Authorizations System Reduces Care Delay
- Electronic Health Records May Be Key to Improving Patient Care, Study Finds
- AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease
- First-Ever AI Test for Early Diagnosis of Alzheimer’s to Be Expanded to Diagnosis of Parkinson’s Disease
- New Self-Learning AI-Based Algorithm Reads Electrocardiograms to Spot Unseen Signs of Heart Failure
- Autonomous Robot Performs COVID-19 Nasal Swab Tests
- Statistical Tool Predicts COVID-19 Peaks Worldwide
- Wireless-Controlled Soft Neural Implant Stimulates Brain Cells
- Tiny Polymer Stent Could Treat Pediatric Urethral Strictures
- Human Torso Simulator Helps Design Brace Innovations
- 3D Bioprinting Rebuilds the Human Heart